Nukkleus Stock Earnings Per Share
| NUKK Stock | USD 1.61 0.04 2.42% |
Nukkleus fundamentals help investors to digest information that contributes to Nukkleus' financial success or failures. It also enables traders to predict the movement of Nukkleus Stock. The fundamental analysis module provides a way to measure Nukkleus' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nukkleus stock.
Nukkleus |
Nukkleus Company Earnings Per Share Analysis
Nukkleus' Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Nukkleus Earnings Per Share | (19.36) X |
Most of Nukkleus' fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nukkleus is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
According to the company disclosure, Nukkleus has an Earnings Per Share of -19.36 times. This is 2075.51% lower than that of the Software sector and significantly lower than that of the Information Technology industry. The earnings per share for all United States stocks is notably higher than that of the company.
Nukkleus Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nukkleus' direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nukkleus could also be used in its relative valuation, which is a method of valuing Nukkleus by comparing valuation metrics of similar companies.Nukkleus is currently under evaluation in earnings per share category among its peers.
Nukkleus Fundamentals
| Return On Equity | -7.42 | ||||
| Return On Asset | -1.15 | ||||
| Profit Margin | (2.53) % | ||||
| Operating Margin | (7.94) % | ||||
| Current Valuation | 6.71 M | ||||
| Shares Outstanding | 2.67 M | ||||
| Shares Owned By Insiders | 34.99 % | ||||
| Shares Owned By Institutions | 2.01 % | ||||
| Number Of Shares Shorted | 21.68 K | ||||
| Price To Earning | (40.00) X | ||||
| Price To Book | 0.69 X | ||||
| Price To Sales | 0.41 X | ||||
| Revenue | 16.22 M | ||||
| Gross Profit | (661.4 K) | ||||
| EBITDA | (1.49 M) | ||||
| Net Income | (11.85 M) | ||||
| Cash And Equivalents | 23.14 K | ||||
| Total Debt | 3.65 M | ||||
| Current Ratio | 0.22 X | ||||
| Book Value Per Share | (6.61) X | ||||
| Cash Flow From Operations | 1.62 M | ||||
| Short Ratio | 0.03 X | ||||
| Earnings Per Share | (19.36) X | ||||
| Number Of Employees | 12 | ||||
| Beta | -0.32 | ||||
| Market Capitalization | 4.4 M | ||||
| Total Asset | 18.36 M | ||||
| Retained Earnings | (14.34 M) | ||||
| Working Capital | 895 K | ||||
| Current Asset | 3.46 M | ||||
| Current Liabilities | 2.56 M | ||||
| Net Asset | 18.36 M |
About Nukkleus Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nukkleus's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nukkleus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nukkleus based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Nukkleus Piotroski F Score and Nukkleus Altman Z Score analysis. For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nukkleus. If investors know Nukkleus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nukkleus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nukkleus is measured differently than its book value, which is the value of Nukkleus that is recorded on the company's balance sheet. Investors also form their own opinion of Nukkleus' value that differs from its market value or its book value, called intrinsic value, which is Nukkleus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nukkleus' market value can be influenced by many factors that don't directly affect Nukkleus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nukkleus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nukkleus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nukkleus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.